4 completed. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 2 | Completed 2 |
Follow elesclomol: new trials by email Literature Review of elesclomol trials Research Report on elesclomol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Elesclomol Sodium, Paclitaxel - Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma | Phase 2 | Completed | GOG Foundation | 58 | 2010-12-13 | 2021-10-20 |
| A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas STA-4783 - Soft Tissue Sarcoma | Phase 2 | Completed | Synta Pharmaceuticals Corp. | 80 | 2004-07-01 | 2006-06-20 |
| STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma STA-4783, Paclitaxel - Melanoma | Phase 1 / Phase 2 | Completed | Synta Pharmaceuticals Corp. | 103 | 2004-05-01 | 2014-03-06 |
| STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) Paclitaxel, Carboplatin, STA 4783 - Stage IIIB Non-Small Cell Lung Cancer, Stage IV Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | Completed | Synta Pharmaceuticals Corp. | 86 | 2004-03-01 | 2008-12-04 |
Brenner Tumor (1) · Carcinoma, Non-Small-Cell Lung (1) · Fallopian Tube Neoplasms (1) · Melanoma (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1) · Sarcoma (1)
Synta Pharmaceuticals Corp. (3) · GOG Foundation (1)
United States (4) · Canada (1)
Bradley J Monk (1)
U10CA027469 (1), U10CA180868 (1)